PREDICTORS OF DISEASE COURSE AFTER THE DISCONTINUATION OF BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH LONG-TERM REMISSION

被引：1
|
作者：
Kadar, G. [1 ]
Czibula, A. [2 ]
Szalay, B. [3 ]
Nagy, K. [4 ]
Pusztai, A. [5 ]
Balog, A. [1 ]
Monostori, E. [2 ]
Vasarhelyi, B. [6 ]
Szekanecz, Z. [5 ]
Kovacs, L. [1 ]
机构：
[1] Univ Szeged, Dept Rheumatol, Szeged, Hungary
[2] Inst Genet, Biol Res Ctr, Szeged, Hungary
[3] Semmelweis Univ, Dept Lab Med, Budapest, Hungary
[4] Markhot Ferenc Hosp, Eger, Hungary
[5] Univ Debrecen, Dept Rheumatol, Fac Med, Debrecen, Hungary
[6] Semmelweis Univ, Dept Lab Med, Budapest, Hungary
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5753
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0312
引用
收藏
页码：1007 / 1007
页数：1
相关论文
共 50 条
  • [21] Predictors of Biological Antirheumatic Drug Discontinuation in Patients with Rheumatoid Arthritis while in Remission
    Kawada, Tomoyuki
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06)
  • [22] Long-term therapy for rheumatoid arthritis
    GomezReino, JJ
    LANCET, 1996, 347 (8998): : 343 - 344
  • [23] Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy
    Colao, Annamaria
    Di Sarno, Antonella
    Guerra, Ermelinda
    Pivonello, Rosario
    Cappabianca, Paolo
    Caranci, Ferdinando
    Elefante, Andrea
    Cavallo, Luigi M.
    Briganti, Francesco
    Cirillo, Sossio
    Lombardi, Gaetano
    CLINICAL ENDOCRINOLOGY, 2007, 67 (03) : 426 - 433
  • [24] LONG-TERM FOLLOW-UP STUDY OF BIOLOGICAL THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS
    Avila, M. G.
    Alonso, A.
    Lasanta, M. Lopez
    Pluma, A.
    Quesada, E.
    Marsal, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 475 - 475
  • [25] MAINTAINING PATIENTS WITH RHEUMATOID ARTHRITIS IN REMISSION ON REDUCED BIOLOGIC THERAPY DOSAGE
    Lloyd, Lois A.
    Owen, Catherine
    Breslin, Anne
    Ahmad, Yasmeen
    RHEUMATOLOGY, 2011, 50 : 113 - 113
  • [26] Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
    Svensson, Bjorn
    Andersson, Maria L. E.
    Bala, Sidona-Valentina
    Forslind, Kristina
    Hafstrom, Ingiald
    BMJ OPEN, 2013, 3 (09):
  • [27] Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort study
    Asai, Shuji
    Fujibayashi, Takayoshi
    Oguchi, Takeshi
    Hanabayashi, Masahiro
    Hayashi, Masatoshi
    Matsubara, Hiroyuki
    Ito, Takayasu
    Yabe, Yuichiro
    Watanabe, Tsuyoshi
    Hirano, Yuji
    Kanayama, Yasuhide
    Kaneko, Atsushi
    Kato, Takefumi
    Takagi, Hideki
    Takahashi, Nobunori
    Funahashi, Koji
    Takemoto, Toki
    Asai, Nobuyuki
    Watanabe, Tatsuo
    Ishiguro, Naoki
    Kojima, Toshihisa
    MODERN RHEUMATOLOGY, 2018, 28 (02) : 221 - 226
  • [28] Long-term efficacy of spa therapy in patients with rheumatoid arthritis
    Mine Karagülle
    Sinan Kardeş
    Müfit Zeki Karagülle
    Rheumatology International, 2018, 38 : 353 - 362
  • [29] Long-term efficacy of spa therapy in patients with rheumatoid arthritis
    Karagulle, Mine
    Kardes, Sinan
    Karagulle, Mufit Zeki
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (03) : 353 - 362
  • [30] 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study
    Yamaguchi, Ayako
    Hirata, Shintaro
    Kubo, Satoshi
    Fukuyo, Shunsuke
    Hanami, Kentaro
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Saito, Kazuyoshi
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 799 - 806
12345